Abstract
Osteoporosis is the most common of the diseases that affect bones. One out of four women will develop osteoporosis after the menopause. But first, what is osteoporosis? Osteoporosis is defined clinically as the loss of bone (ostopaenia) sufficient to result in fractures with minimal trauma, generally of the spine, but also of the hip and wrist.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Garn, S.M., Rohmann, C. G. and Wagner, B. (1967). Bone loss as a general phenomenon in man. Fed. Proc., 26, 1729
Dequeker, J. (1975). Bone and ageing. Ann. Rheum. Dis., 34, 100
White, M. P., Bergfeld, M. A., Murphy, N. A., Avioli, L. V. and Teitelbaum, S. L. (1982). Postmenopausal osteoporosis: A heterogeneous disorder as assessed by histomorphometric analysed of iliac crest bone from untreated patients. Am. J. Med., 72, 193
Frost, H. M. (1973). The spinal osteoporosis. Clin. Endocrinol., 2, 257
Lewis, A. F. (1981). Fracture of neck of the femur: changing incidence. Br. Med. J., 283, 1217
Albright, F. and Reifenstein, E. C. (1948). The Parathyroid Glands and Metabolic Bone Desease. ( Baltimore: Williams and Wilkins )
Dequeker, J. (1972). Bone Loss in Normal and Pathological Conditions, p. 217. ( Leuven: University Press )
Lindsay, R., Coutts, J. T. R. and Hart, D. M. (1977). The effect of endogenous oestrogen on plasma and urinary calcium and phosphate in oophorectomized women. Clin. Endocrinol., 6, 87
Heaney, R. P. (1981). Osteoporosis. In Bronner, F. and Cobum, J. W. (eds) Disorders of Mineral Metabolism, pp. 91–117. ( New York: Academic Press )
Dequeker, J., Burssens, A., Creytens, G. and Bouillon, R. (1975). Ageing of bone. Its relation to osteoporosis in postmenopausal women. In van Keep, P. A. and Lauritzen, C. (eds) Frontiers of Hormone Res. Vol. 3, Estrogens in the Post-Menopause, pp. 116–130. ( Basel: Karger )
Dequeker, J., Goris, P. and Uyttenhoeven, R. (1982). Osteoporosis and osteoarthritis (osteoarthrosis) anthropometic distinctions. J. Am. Med Assoc., 249, 1448
Roh, Y. S., Dequeker, J. and Mulier, J. C. (1973). Osteoarthrosis at the hand skeleton in primary osteoarthrosis of the hip and in normal controls. Clin. Orthop. Rel. Res., 90, 90
Roh, Y. S., Dequeker,J. and Mulier, J. C. (1974). Bone mass in osteoarthrosis, measured in vivo by photon absorption. J. Bone Joint Surg., 56A, 587
Roh, Y. S., Dequeker, J. and Mulier, J. C. (1974). Trabecular pattern of the upper end of the femur in primary osteoarthrosis and in symptomatic osteoporosis. Belg. Tijdschr. Radiol., 57, 89
Foss, M. V. L. and Byers, P. D. (1972). Bone density, osteoarthrosis of the hip and fracture of the upper end of the femur. Ann. Rheum. Dis., 31, 259
Frumar, A. M., Meldrum, D. R., Geola, F., Shamonti, I. M., Tataryn, I. V., Deftos, L. J. and Judd, H. L. (1980). Relationship of fasting urinary calcium to circulating estrogen and body weight in postmenopausal women. J. Clin. Endocrinol. Metabol., 50, 70
Dequeker, J. and Johnston, C. C. (1982). Non-Invasive Bone Measurements: Methodological Problems. ( Oxford — Washington D.C.: IRL Press )
Rich, C., Bernstein, D. S., Gates, S., Heaney, R. P., Johnston, C. C., Rosenberg, C. A., Schnaper, H. W., Tewkburry, R. B. and Williams, G. A. (1966). Factors involved in an objective study of the efficacy of treatment of osteoporosis. Clin. Orthop. Relat. Res., 45, 63
Lindsay, R., Aitken, J. M., Anderson, J. B., Hart, D. M., MacDonald, E. B. C. and Clarke, A. C. (1976). Long-term prevention of postmenopausal osteoporosis by oestrogen. Lancet, 1, 1038
Horsman,A., Gallagher, J. C., Simpson, M. and Nordin, B. E. C. (1977). Prospective trial of oestrogen and calcium in postmenopausal women. Br. Med. J., 2, 789
Recker, R. R., Saville, P. D. and Heaney, R. P. (1977). Effect of oestrogens and calcium carbonate on bone loss in postmenopausal women. Ann. Intern. Med., 87, 649
Christiansen, C., Christensen, M. S., McNair, P., Hagen, C., Stocklund, K. and Transbøl, I. (1980). Prevention of early postmenopausal bone loss: Controlled 2-year study in 315 normal females. Eur. J. Clin. Invest., 10, 273
Hutchinson, T. A., Polansky, S. M. and Feinstein, A. R. (1979). Post-meno-pausal oestrogens protect against fractures of hip and distal radius. A case-control study. Lancet, 2, 705
Weiss, N. S., Ure, C. L., Ballard, J. H., Williams, A. R. and Daling, J. R. (1980). Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N. Engl. J. Med., 303, 1195
Dequeker, J. and Ferin, J. (1976). Effect of long-term estrogen therapy on bone remodelling in women with a natural menopause: cross-sectional and longitudinal study. In van Keep, P. A., Greenblatt, R. B. and Albeaux-Fernet, M. (eds) Consensus on Menopause Research, pp. 124–131. ( Lancaster: MTP Press )
Lindsay, R., Fogelman, I. and Hart, D. M. (1982). Minimum effective dose of oestrogen for protection against postmenopausal bone loss (Abstract) Calcif. Tiss. Int., 34 (Suppl.I), S-33
Thorn, M.H., White, P. J., Williams, R. M., Sturdee, D. W., Paterson, M. E. L. and Wade-Evans, T. (1979). Prevention of endometrial disease in climacteric women receiving oestrogen therapy. Lancet, 2, 455
Gambrell, R. D., Jr. (1982). Role of hormones in the etiology and prevention of endometrial and breast cancer. Acta Obstet. Gynecol. Scand., 106, 37
Lindsay, R., Hart, D. M., Maclean, A., Clarke, A. C., Kraszewski, A. and Garwood, J. (1978). Bone response to termination of oestrogen treatment. Lancet, 1, 1325
Horsman,A., Nordin, B. E. C. and Crilly, R. G. (1979). Effect on bone of withdrawal of oestrogen therapy. Lancet, 2, 33
Christiansen, C., Christensen, M. S. and Transbøl, I. (1981). Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet, 1, 459
Lindsay, R., Hart, D. M., Purdie, D., Fergusson, M. M., Clarke, A. C. and Kraszewski, A. (1978). Comparative effects of oestrogen and progestogen on bone loss in postmenopausal women. Clin. Sci. Mol. Med., 54, 193
Dequeker, J., De Muylder, E. and Ferin, J. (1977). The effect of long-term lynestrenol treatment on bone mass in cycling women. Contraception, 15, 717
Dequeker, J. and De Muylder, E. (1982). Long-term progestogen treatment and bone remodelling in perimenopausal women: a longitudinal study. Maturitas, 4, 309
Gallagher, J. C. (1981). Biochemical effects of estrogen and progesterone on calcium metabolism. In De Luca, H. F., Frost, H. M., Jee,W. S. S., Johnston, C. C. and Parfitt, A. M. (eds) Osteoporosis: Recent Advantages in Pathogenesis and Treatment, pp. 231–238. ( Baltimore: University Park Press )
Johnston, C. C., Norton, J. A., Khairi, R. A. and Longcope, C. (1979). Age-related bone loss. In Barzel, U.S. (ed.) Osteoporosis II, pp. 91–100. ( New York: Grune and Stratton )
Stevenson, J. C., Abeyasekera, G., Hillard, C., Phang, K. G., MacIntyre, I., Campbell, S., Townsend, P. T., Young, O. and Whitehead, M. I. (1981). Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of estrogens. Lancet, 1, 693
Heaney, R. P. (1965). A unified concept of osteoporosis. Am. J. Med., 39, 877
Deftos, L. J., Weisman, W. H., Williams, G. W., Parthemore, J. G., Judd, H. L., Karpf, D. B., Frumar, A. M. and Davidson, B. J. (1980). Influence of age and sex on plasma calcitonin in human beings. N. Engl. J. Med., 302, 1351
Yoshioka, T., Sato, B., Matsumoto, K. and Ono, K. (1980). Steroid receptors in osteoblasts. Clin. Orthop. Rel. Res., 148, 297
Chen, T. L., Aronow, L. and Feldman, D. (1977). Glucocorticoid receptors and inhibition of bone cell growth in primary culture. Endocrinology., 100, 619
Nordin, B. E. C., Horsman, A., Crilly, R. G., Marshall, D. H. and Simpson, M. (1980). Treatment of spinal osteoporosis in postmenopausal women. Br. Med. J., 280, 451
Heaney, R. P., Recker, R. R. and Saville, P. D. (1978). Menopausal changes in calcium balance performance. J. Lab. Clin. Med., 92, 953
Matkovic, V., Kostial, K., Simonovic, I., Buzina, R., Brodarec, A. and Nordin, B. E. C. (1979). Bone status and fracture rates in two regions of Yugoslavia. Am. J. Clin. Nutr., 32, 540
Nordin, B. E. C., Horsman, A. and Gallagher, J. C. (1973). Effect of various therapies on bone loss in women. In Kuhlencordt, F. and Kruse, H. P. (eds) Tenth European Symposium on Calcified Tissues. pp. 451–454. ( Berlin: Springer Verlag )
Dequeker, J. and Van Tendeloo, G. (1982). Metacarpal bone mass and upper-extremity strength in 18-year-old boys. Invest. Radiol., 17, 427
Doyle, F., Brown, J. and Lachance, C. (1970). Relation between bone mass and muscle weight. Lancet, 1, 391
Saville, P.D. and White, M. P. (1969). Muscle and bone hypertrophy. Positive effect of running exercise in the rat. Clin. Orthop., 65, 81
Nilsson, B. E. and Westlin, N. E. (1971). Bone density in athletes. Clin. Orthop., 77, 179
Dalén, N, and Olsson, K. E. (1974). Bone mineral content and physical activity. Acta Orthop. Scand., 45, 170
Huddleston, A. L., Rockwell, D., Kulund, D. N. and Harrison, R. B. (1980). Bone mass in lifetime tennis athletes. J. Am. Med. Assoc., 244, 1107
Aloia, J.F., Cohn, S. H., Babu,T., Abesalis, C., Kalici, N. and Ellis, K. (1978). Skeletal mass and body composition in marathon runners. Metabolism, 27, 1793
Aloia, J. F., Cohn, S. H., Ostuni, J. A., Cane, R. and Ellis, K. (1978). Prevention of involutional bone loss by exercise. Ann. Intern. Med., 89, 356
Krølner, B., Toft, B., Nielsen, S. P. and Tøndevold, E. (1983). Physical exercise as prophylaxis against involutional vertebral bone loss; a controlled trial. Clin. Sci., 64, 541
Lamberg, B. A. and Kuhlbäck, B. (1959). Effect of chlorothiazide and hydrochlorothiazide on the excretion of calcium in urine. Scand. J. Clin. Lab. Invest., 11, 351
Wasnich, R. D., Benfante, R. J., Yano,K., Heilbrun, L. and Vogel, J. M. (1983). Thiazide effect on the mineral content of bone. N. Engl. J. Med., 309, 344
Pak, C. Y., Zisman, E., Evens, R., Jowley, J., Delea, C. S. and Bartter, F. C. (1969). The treatment of osteoporosis with calcium infusions. Am. J. Med., 47, 7
Dudl, R. J., Ensinck, J. W., Baylink, D., Chesnut, C. H., Sherrard, D. and Nelp, W. B. (1973). Evaluation of intravenous calcium as therapy for osteoporosis. Am. J. Med., 55, 631
Walton, J., Dominguez, M. and Bartter, F. C. (1975). Effects of calcium infusions in patients with postmenopausal oesteoporosis. Metab. Clin. Exp., 24, 849
Dequeker, J., Verstraeten, A., Collee, G. and Gielen, J. (1981). Confrontation osteoarthrosis/osteoporosis: A cross-sectional and longitudinal study. In Peyron, J.G. (ed.) Epidemiology of Osteoarthritis, pp. 147–155. ( Paris: Geigy Paris )
Riggs, B. L., Seeman, E., Hodgson, S. F., Taves, D. R. and O’Fallon, W. M. (1982). Effects of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. N. Engl. J. Med., 306, 446
Dequeker, J., Heylen, H., Van Steenkiste, J. and Vroninckx, R. (1972). Urinary total hydrocyproline, calcium and phosphorus excretion after adminstration of calcium and oestrogen to postmenopausal women. Pharmacology, 7, 321
Chesnut, C. H., Nelp, W. B., Baylink, D. J. and Denney, J. D. (1977). Effect of methandrostenolone on postmenopausal bone wasting as assessed by changes in total bone mineral mass. Metabolism, 26, 267
Chesnut, C. H., Ivey, J. L., Nelp, W. B. and Baylink, D. J. (1979). Assessment of anabolic steroids and calcitonin in the treatment of osteoporosis. In Barzel, U.S. (ed.) Osteoporosis II, pp. 135–150. ( New York, San Francisco and London: Grune and Stratton )
Frost, H. M. (1973). The origin and nature of transients in human bone remodelling dynamics. In Frame, B., Parfitt, A. M. and Duncan, H (eds) Clinical Aspects of Metabolic Bone Disease, pp. 124–137. ( Amsterdam: Excerpta Medica )
Lindsay, R., Hart, D. M. and Kraszewski, A. (1980). Prospective double-blind trial of synthetic steroid (Org. 0D14) for preventing postmenopausal osteoporosis. Br. Med. J., 1, 1207
Aaron, J. E., Gallagher, J. C. and Nordin, B. E. C. (1974). Seasonal variation of histological osteomalacia in femoral-neck fractures. Lancet, 2, 84
Anderson, J. and Nordin, B. E. C. (1974). Frequency of osteomalacia and osteoporosis in fractures of the proximal femur. Lancet, 1, 229
Riggs, B. L., Jowsey, J., Kelly, P. J., Hoffman, D. L. and Arnaud, C. D. (1976). Effects of oral therapy with calcium and vitamin D in primary osteoporosis. J. Clin. Endocrinol. Metab., 42, 1139
Recker, R. R. (1981). Continuous treatment of osteoporosis: current status. Orthop. Clin. North. Am., 12, 611
Olah, A. J., Reutter, F. W. and Dambacher, M. A. (1978). Effects of combined therapy with sodium fluoride and high doses of vitamin D in osteoporosis. A histomorphometric study in the iliac crest. In Courvoisier, B., Donath, A. and Baud, C. A. (eds) Fluoride and Bone, pp. 242–246. ( Geneva: Hans Huber )
Gallagher, J. C., Riggs, B. L., Eisman, J., Hamstra, A., Arnaud, S. B. and De Luca, M. F. (1979). Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients. J. Clin. Invest., 64, 729
Geusens, P., Dequeker, J. and Verstraeten, A. (1983). Age-related blood changes in hip osteoarthritis patients: a possible indicator of bone quality. Ann. Rheum. Dis., 42, 112
Cohen, H. N., Farrah, D., Fogelman, I., Goll, C. C., Beastall, G. H., McIntosh, W. B., Fletcher, M. and Boyle, I, T. (1980). A low dose regime of 1α-hydroxy-vitamin D3 in the management of senile osteoporosis. A pilot study. Clin. Endocrinol., 12, 537
Hoikka,V., Alhava, E. M., Aro, A., Karjalainen, P. and Rehnberg, V. (1980). Treatment of osteoporosis with 1-alpha-hydroxycholecalciferol and calcium. Acta Med. Scand., 207, 221
Christiansen, C., Christensen, M. S., Rødbro, P., Hagen, C. Transbøl, I. (1981). Effect of 1, 25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis. Eur. J. Clin. Invest., 11, 305
Briançon, D. and Meunier, P. J. (1981). Treatment of osteoporosis with fluoride, calcium and vitamin D. Orthop. Clin. North Am., 12, 629
Harrison, J. E., McNeill, K. G., Sturtridge, W. C., Bayley, T. A., Fornasier, V., Williams, C. and Tam, C. (1981). Three-year changes in bone mineral mass of postmenopausal osteoporotic patients based on neutron activation analysis of the central third of the skeleton. J. Clin. Endocrinol. Metab., 52, 751
Dambacher, M. A., Lauffenberger, T., Lammle, B. and Haas, H. G. (1978). Long term effects of sodium fluoride on osteoporosis. In Courvoisier, B., Donath, A. and Baud, C. A. (eds) Fluoride and Bone, pp. 238–246. ( Bern, Stuttgart, Vienna: Hans Huber )
Ringe, J. D., Kruse, H. P. and Kuhlencordt, F. (1978). Long-term treatment of primary osteoporosis by sodium fluoride. In Courvoisier, B., Donath, A. and Baud, C. A. (eds) Fluoride and Bone, pp. 228–232. ( Bern, Stuttgart, Vienna: Hans Huber )
Franke, J. (1978). Our experience in the treatment of osteoporosis with relative low sodium-fluoride doses. In Courvoisier, B., Donath, A. and Baud, C. A. (eds) Fluoride and Bone, pp. 256–262. ( Bern, Stuttgart, Vienna: Hans Huber )
Riggs, B. L., Hodgson, S. F., Hoffman, D. L., Kelly, P. J., Johnson, K. A. and Taves, D. (1980). Treatment of primary osteoporosis with fluoride and calcium. J. Am. Med. Assoc., 243, 446
Reutter, F. W. and Olah, A. J. (1978). Bone biopsy findings and clinical observations in long-term treatment of osteoporosis with sodium fluoride and vitamin D3. In Courvoisier, B., Donath, A. and Baud, C. A. (eds) Fluoride and Bone, pp. 249–255. ( Bern, Stuttgart, Vienna: Hans Huber )
Effects of prolonged administration of porcine calcitonin in postmenopausal osteoporosis. J. Clin. Endocrinol., 33, 752
Jowsey, J., Riggs, B. L., Kelly, P. J. and Hoffman, D. L. (1978). Calcium and salmon calcitonin in treatment of osteoporosis. J. Clin. Endocrinol. Metab., 47, 633
Meunier, P., Bressot, C., Vignon, E., Edouard, C., Alexandre, C., Courpron, P. and Laurent, J. (1978). Radiological and histological evolution of postmenopausal osteoporosis treated with sodium fluoride-vitamin D-calcium. In Courvoisier, B., Donath, A. and Baud, C. A. (eds) Fluoride and Bone, pp. 263–276. ( Bern, Stuttgart, Vienna: Hans Huber )
Frost, H. M. (1973). Bone Remodelling and its Relationship to Metabolic Bone Diseases, Vol 3. ( Springfield, Ill.: C.C.Thomas )
Reeve, J., Meunier, P. J., Parsons, J. A., Kleinerman, L., Neer, R. M., Renier, J., Slovik, D., Vismans, F. J., Bernat, M., Bijvoet, O. L., Courpron, P., Edouard, C, and Potts, J, T., Jr. (1980). Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis. A multicenter trial. Br. Med. J., 280, 1340
Rasmussen, H., Bordier, P., Marie, P., Auquier, L., Eisinger, J. B., Kuntz, D., Caulin, F., Argemi,B., Gueris,J. and Julien, A. (1980). Effects of combined therapy with phosphate and calcitonin on bone volume in osteoporosis. Metab. Bone Dis. Relat. Res., 2, 107
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 MTP Press Limited
About this chapter
Cite this chapter
Dequeker, J., Geusens, P., Verstraeten, A. (1984). Osteoporosis and its treatment. In: van Herendael, H., van Herendael, B., Riphagen, F.E., Goessens, L., van der Pas, H. (eds) The Climacteric: An Update. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-5608-7_17
Download citation
DOI: https://doi.org/10.1007/978-94-009-5608-7_17
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8973-9
Online ISBN: 978-94-009-5608-7
eBook Packages: Springer Book Archive